Sign up to save your podcasts
Or
Share ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer
This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC).
View all episodes
By Sam and Karine
4.8
164164 ratings
This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC).
More shows like Two Onc Docs
View all
NEJM This Week
313 Listeners
Research To Practice | Oncology Videos
110 Listeners
JAMA Clinical Reviews
488 Listeners
ASCO Daily News
55 Listeners
The Curbsiders Internal Medicine Podcast
3,317 Listeners
Core IM | Internal Medicine Podcast
1,069 Listeners
The ONS Podcast
190 Listeners
OncoPharm
182 Listeners
ASCO Guidelines
46 Listeners
Plenary Session
750 Listeners
The Clinical Problem Solvers
506 Listeners
Oncology Today with Dr Neil Love
53 Listeners
The Curious Clinicians
365 Listeners
Blood Cancer Talks
48 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
37 Listeners